Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Parkinson’s disease

New guidelines on Parkinson’s disease released by NICE

The National Institute for Health and Care Excellence (NICE), England’s health technology assessment body, has released new clinical guidelines on the diagnosis and management of Parkinson’s disease in adults aged 18 years and over[1].

The updated guidelines, released on 19 July 2017, aim to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.

Dudley Group NHS Foundation Trust neurology specialist pharmacist Janine Barnes was a member of the guideline development group for the Parkinson’s disease update, the first time there has been pharmacist involvement in this area. According to Barnes, from a pharmacy angle, the main changes to the guidelines concern the use of levodopa as a first-line option for patients with motor problems and protein re-distribution.

“[It recommends that] the main protein load is taken in the evening when patients are prescribed levodopa so as to prevent any potential protein interaction occurring with food,” she explains.

“There is [also] greater emphasis on multidisciplinary team working and on the role of therapy in the management of Parkinson’s disease, and specifically with therapists trained in the area of Parkinson’s disease rather than generalists.”

Other areas covered by the guidelines which are aimed at healthcare professionals, commissioners and providers, and adults with Parkinson’s disease, their families and carers include communication with people with Parkinson’s disease and their carers; pharmacological and non-pharmacological management of motor and non-motor symptoms; and impulse control disorders.

The next review date for the guidelines is July 2019.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203225

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Pathology and Therapeutics for Pharmacists

    Pathology and Therapeutics for Pharmacists

    An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.

    £54.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Woman with Parkinson's disease

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.